MolPort-001-783-420

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

39 Suppliers, 21 USDMF, 5 CEP/COS, 6 EU WC, 18 NDC API, 22 Listed Suppliers

DEVELOPMENTS

270 Drug(s) in Development

270 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Imports

INTERMEDIATES

3 Suppliers

3 Suppliers

DOSSIERs // Finished Dosage Forms

135 Dossiers, 75 FDA Orange Book, 15 Europe, 6 Canada, 11 Australia, 6 South Africa, 22 Listed Dossiers

DRUG PRODUCT COMPOSITION

INJECTABLE;INJECTION - 100MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 1GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 200MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 2GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 25MG, CAPSULE;ORAL - 50MG

RELATED EXCIPIENT COMPANIES

Suppliers, 20 Kerry, 17 Roquette, 17 SPI Pharma, 11 Microlex e.U, 10 Gangwal Healthcare, 9 Sigachi Industries, 4 ACG Worldwide, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 DFE Pharma, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 4 Gangwal Chemicals, 3 Lonza Capsugel, 3 Prachin Chemical, 3 Ingredion Pharma Solutions, 2 Nanjing Well Pharmaceutical, 2 Rochem International Inc, 2 BASF, 2 Seppic, 2 Pharmatrans-Sanaq, 2 Vasa Pharmachem, 1 Alcedo Pharmachem, 1 Qualicaps, 1 Shijiazhuang Huaxu Pharmaceutical, 1 DKSH, 1 Finar, 1 Minakem, 1 Ideal Cures Pvt Ltd, 1 NEWEDGE Overseas, 1 Jai Radhe Sales, 1 Pfanstiehl, 1 Chynops Pharma

EXCIPIENTS BY APPLICATIONS

64 Fillers, Diluents & Binders, 28 Direct Compression, 16 Chewable & Orodispersible Aids, 16 Lubricants & Glidants, 14 Taste Masking, 14 Co-Processed Excipients, 13 Thickeners and Stabilizers, 12 Granulation, 11 Disintegrants & Superdisintegrants, 8 Empty Capsules, 8 Coating Systems & Additives, 5 Controlled & Modified Release, 5 Parenteral, 5 Film Formers & Plasticizers, 2 Topical, 2 Emulsifying Agents, 2 API Stability Enhancers, 1 Solubilizers, 1 Rheology Modifiers

GLOBAL SALES INFORMATION

7 US Medicaid Prescriptions, 11 Finished Drug Prices

MARKET PLACE

14 APIs, 18 DOSSIERS // FDF

PATENTS

12 US Patents

12 US Patents

ANALYTICAL SOLUTION(s)

1 EDQM Standards, 5 USP Standards, 5 Other Ref. Standards

DIGITAL CONTENT

1 Data Compilation & Company Tracker #PharmaFlow, 68 News

Approved Marketing Authorisations (MA) containing MolPort-001-783-420 in Europe. Original Data : EMA Website

MolPort-001-783-420

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

39 Suppliers

21 USDMF

5 CEP/COS

6 EU WC

18 NDC API

22 Listed Suppliers

DEVELOPMENTS

270 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Imports

INTERMEDIATES

3 Suppliers

DOSSIERs // Finished Dosage Forms

135 Dossiers

75 FDA Orange Book

15 Europe

6 Canada

11 Australia

6 South Africa

22 Listed Dossiers

DRUG PRODUCT COMPOSITION

INJECTABLE;INJECTION - 100MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 1GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 200MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 2GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 25MG

CAPSULE;ORAL - 50MG

RELATED EXCIPIENT COMPANIES

Suppliers

20 Kerry

17 Roquette

17 SPI Pharma

11 Microlex e.U

10 Gangwal Healthcare

9 Sigachi Industries

4 ACG Worldwide

4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

4 DFE Pharma

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

4 Gangwal Chemicals

3 Lonza Capsugel

3 Prachin Chemical

3 Ingredion Pharma Solutions

2 Nanjing Well Pharmaceutical

2 Rochem International Inc

2 BASF

2 Seppic

2 Pharmatrans-Sanaq

2 Vasa Pharmachem

1 Alcedo Pharmachem

1 Qualicaps

1 Shijiazhuang Huaxu Pharmaceutical

1 DKSH

1 Finar

1 Minakem

1 Ideal Cures Pvt Ltd

1 NEWEDGE Overseas

1 Jai Radhe Sales

1 Pfanstiehl

1 Chynops Pharma

EXCIPIENTS BY APPLICATIONS

64 Fillers, Diluents & Binders

28 Direct Compression

16 Chewable & Orodispersible Aids

16 Lubricants & Glidants

14 Taste Masking

14 Co-Processed Excipients

13 Thickeners and Stabilizers

12 Granulation

11 Disintegrants & Superdisintegrants

8 Empty Capsules

INJECTABLE;INJECTION - 100MG/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 1GM/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 200MG/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 2GM/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 500MG/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons